BioSpace News Archive

Genetown

Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Senior Notes Due 2042

Hologic announced today that holders of the 2.00% Convertible Senior Notes due 2042 issued March 5, 2012 have the right to surrender their notes for repurchase by the Company.

January 29, 2018
·
4 min read
Drug Development

Sierra Oncology to Present at the DNA Damage Response Therapeutics Summit

The presentation is scheduled for 2:15 pm Eastern Time on February 1, 2018.

January 29, 2018
·
4 min read
Deals

Medtronic Closes $28M Purchase of QT Vascular’s Chocolate PTA Balloon Catheter

Independently, QT Vascular will continue to develop and market its other products including a drug coated version of Chocolate PTA.

January 29, 2018
·
2 min read
United Neuroscience Announces Development Plans for Vaccine to Prevent CTE

As part of the program introduction, Dr. Verma and NFL broadcaster Solomon Wilcots will discuss the medical need and opportunity for the CTE vaccine program with journalists Jan. 30-31 on Super Bowl Radio Row in Minneapolis.

January 29, 2018
·
3 min read
Avicanna Completes 2nd Equity Financing & Welcomes New Strategic Shareholder

Avicanna is pleased to announce the completion of its second non-brokered private placement offering for units in Avicanna.

January 29, 2018
·
4 min read
Bioness Receives Health Canada Approval for StimRouter Neuromodulation System

The Canadian medical device license provides approval to commercialize StimRouter and begin sales throughout Canada.

January 29, 2018
·
4 min read
BioMidwest

DePuy Synthes’New Study on Total Hip Arthroplasty (THA) Outcomes With Anterior Approach Show Less Reported Pain, Fewer Narcotics and Better Hip Function in the First 90 Days

DePuy Synthes today announced the first systematic review of prospective studies comparing postoperative outcomes through 90 days of Anterior Approach versus Posterior Approach in primary total hip arthroplasty.

January 29, 2018
·
3 min read
Business

Emmaus Life Sciences Announces Medicaid Coverage of Endari (L-glutamine oral powder) for Sickle Cell Disease in the United States

Emmaus Life Sciences announced today that it has a Medicaid Drug Rebate Agreement with the Centers for Medicare & Medicaid Services allowing coverage of Endari (L-glutamine oral powder) to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older.

January 29, 2018
·
5 min read
Business

Endologix Appoints Greg Morrow as Chief Marketing Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Endologix announced today that it has appointed Greg Morrow as the Company’s Chief Marketing Officer, effective immediately.

January 29, 2018
·
5 min read
Policy

Ceapro Inc. to Consider Judgements in AVAC Ltd. Actions

Ceapro announced today that Mr. Justice C.M. Jones issued his written decision with respect to the two claims brought by AVAC Ltd. (“AVAC”) in 2011 and 2012 against Ceapro and certain of its wholly owned subsidiaries.

January 29, 2018
·
2 min read